Home About Clinical Research News Insights Podcasts Videos SCOPE Events

Stay Connected to Clinical Research—All Year Long

SCOPE 365 is the year-round digital extension of SCOPE, bringing clinical research professionals continuous access to insights, live virtual meetups, expert interviews, and premium intelligence products. It’s a centralized hub designed to help sponsors, CROs, sites, and solution providers stay on the pulse of the industry, elevate thought leadership, and maintain momentum between SCOPE’s global conferences.

Latest In Clinical Trials

AI in Clinical Financial Operations: The Hidden Bottleneck

Insights from SCOPE | Financial operations influence every stage of a clinical trial, yet they remain one of the most overlooked opportunities for AI. Explore how connected financial workflows can reduce administrative burden, improve startup, strengthen site relationships, and create better operational visibility. more...

July 09, 2026
The Scope of Things: Scaling AI Agents In Clinical Trials

Clinical Research News | Artificial intelligence agents are beginning to reshape clinical trial operations, but sponsors are still hesitating. Raj Indupuri, CEO of eClinical Solutions, joined the latest episode of The Scope of Things, hosted by Deborah Borfitz, to break down the three main obstacles hindering AI adoption: data readiness, governance and trust, and operating model change. more...

July 09, 2026
Insilico Medicine Launches Phase III Trial for AI-Developed Drug

Clinical Research News | Insilico Medicine is launching a phase III clinical program for rentosertib, its potentially first-in-class oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive, age-related fibrotic lung disease with high unmet medical need. It is the next step in making AI-discovered drugs a reality for patients. more...

July 08, 2026
Keeping it Simple: Protocol Simplicity as a Scalability Strategy

Insights from SCOPE | Protocol complexity affects far more than study design. Explore how simplifying protocols can reduce site burden, improve study startup, strengthen scalability, and help clinical teams focus on collecting the data that matters most for successful trial execution. more...

July 07, 2026
Machine-Readable Protocols: The Foundation of Scalable AI Execution

Insights from SCOPE | Machine-readable protocols can do more than streamline documentation. They create the structured foundation AI needs to improve study startup, feasibility, and trial execution. Explore why the future of clinical operations may begin with rethinking the protocol itself. more...

July 02, 2026
Follow the Money: Liver Cell-Reprogramming Therapy, Full-Length Dystrophin Trial, Next-Gen Neuroplastogen

Clinical Research News | cAMPfield is launching a global phase 2b trial for moderate-to-severe ulcerative colitis and a global phase 2 for Crohn’s disease; Gero intends to advance a portfolio of both disease-modifying and aging-slowing programs in parallel; ClearNote Health continues commercial clinical study execution and broader global access; and more. more...

July 01, 2026